Mr. Dearen has over 20 years of experience in medical devices and pharmaceutical industries. Previously Chief Operating and Financial Officer at Vessix Vascular, Mr. Dearen was responsible for integration following the acquisition of Vessix by Boston Scientific. Prior to that, Mr. Dearen was CFO of a number of life science and venture capital firms including Miraval Holding, Q3DM, Fairbanks Systems Group, ESI Software, Medication Delivery Devices and positions with Ventana Growth Funds.
Current role